They are related. My firm put me in contact with a patient services person at Sloan who recommended Weill. According to them, it's a good place to start.
I have 4 of my doctors: 2 say go on Tamoxifen and two say don't. My stereotactic biopsy slides (not the surgical one) was seen by three labs. Two said hyperplasia and one said carcinoma in situ. Both leave me with having to watch very carefully, but once you have an in situ report docs tend to recommend Tamoxifen. Since these docs have "seen it all" I'm hoping for some clarity. My surgeon feels the surgical biopsy is a better indicator of what is really there while the MD Oncologist feels otherwise. I'm sure you realize that I would like to side with the surgeon but it wouldn't be prudent to leave this alone.
I'm thankful I don't have cancer, but I can't make any decision with my docs not in agreement. I feel that bringing the slides to them may come up with even another finding, but I have no choice. I need a tie breaker.